Dec 18, 2025 07:00AM Nutriband responds to fentanyl weapon of mass destruction designation

Nov 24, 2025 07:00AM Nutriband Inc. To Present at The 2025 Noble Capital Markets Emerging Growth Equity Conference

Oct 28, 2025 07:05AM Nutriband receives FDA feedback on abuse deterrent fentanyl patch

Oct 27, 2025 07:02AM Nutriband co-founder Gareth Sheridan returns as CEO

Oct 10, 2025 07:00AM Nutriband partners with Brand Institute for fentanyl patch naming

Oct 8, 2025 08:31AM Nutriband files provisional patent for enhanced abuse deterrent technology

Sep 10, 2025 09:16AM Nutriband reports 50.87% revenue increase in first half of 2025

Aug 8, 2025 08:01AM FDA approves meeting request for Nutriband's fentanyl patch development

Jul 18, 2025 09:16AM Nutriband sets dates for 25% preferred stock dividend

Jul 2, 2025 08:06AM Nutriband (NTRB) Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

Jun 9, 2025 07:31AM Nutriband (NTRB) Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

Apr 30, 2025 07:30AM Nutriband (NTRB) CEO Publishes Letter to Shareholders

Apr 11, 2025 07:01AM Nutriband (NTRB) Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

Apr 4, 2025 07:01AM Nutriband (NTRB) Signs Partnership Agreement with Charlotte FC

Feb 21, 2025 07:01AM Nutriband (NTRB) Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

Feb 13, 2025 07:10AM Nutriband (NTRB) and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Feb 7, 2025 08:45AM Nutriband (NTRB) Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa

Dec 31, 2024 07:00AM Nutriband (NTRB) Issues Letter to Shareholders

Dec 27, 2024 09:25AM Nutriband (NTRB) Extends Chinese Patent to Macao for its AVERSA Abuse Deterrent Transdermal Technology

Nov 27, 2024 07:01AM Nutriband (NTRB) Receives Hong Kong Patent Notice of Publication for Its Aversa Abuse Deterrent Transdermal Technology

Oct 31, 2024 08:35AM Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

Oct 17, 2024 07:00AM Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

Oct 2, 2024 07:00AM Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

Sep 24, 2024 07:03AM Nutriband (NTRB) Receives China Patent Notice of Allowance for Aversa Abuse Deterrent Transdermal Technology

Sep 24, 2024 07:00AM Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

Sep 20, 2024 06:52AM Nutriband (NTRB) Licenses Bitrex Brand Aversive Agent for Its Lead Product

Sep 20, 2024 06:50AM Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

Sep 16, 2024 04:02PM Nutriband (NTRB) Announces $1M Share Buyback

Sep 16, 2024 04:00PM Nutriband Inc. Authorizes $1M Share Buyback Program

Sep 4, 2024 07:00AM Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Jul 19, 2024 07:00AM Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

Jul 15, 2024 07:03AM Nutriband (NTRB) Receives Notice of Allowance for U.S. Trademark Covering AVERSA Abuse Deterrent Technology

Jul 15, 2024 07:00AM Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

Jun 20, 2024 07:04AM Nutriband (NTRB) Provides Product Development Update for Aversa Fentanyl

Jun 20, 2024 07:00AM Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl